---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-25-000113"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2025-10-27T23:59:59+00:00"
generated_at: "2026-05-17T02:12:50.272553+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Maravai LifeSciences reduces board from 11 to 8; three directors resign

## Summary
- Benjamin Daverman, Jessica Hopfield, and Murali Prahalad resigned from the Board effective Oct 21, 2025.
- Board size reduced from 11 to 8 directors effective Oct 27, 2025; resignations were not due to any disagreement.
- R. Andrew Eckert named chair of Nominating, Governance and Risk Committee and member of Audit Committee.
- Gregory T. Lucier appointed to Nominating, Governance and Risk Committee; unvested RSUs for departing directors accelerated.

## SEC filing metadata
- accession: 0001823239-25-000113
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2025-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000113/0001823239-25-000113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000113/mrvi-20251021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-25-000113
- JSON: https://secwatch.observer/filing/0001823239-25-000113.json
- Plain text: https://secwatch.observer/filing/0001823239-25-000113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
